Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Cupressuflavone
Potential treatment - theoretical effect Natural product Antiviral Aug/05/2020
Succinylsulfathiazole
Potential treatment - theoretical effect Experimental Antiviral Aug/05/2020
Protirelin
Potential treatment - theoretical effect Experimental Antiviral Aug/05/2020
Uridine triphosphate
Potential treatment - theoretical effect Natural product Antiviral Aug/05/2020
Sulfaperin
Potential treatment - theoretical effect Experimental Antiviral Aug/05/2020
Fidarestat
Potential treatment - theoretical effect Experimental Antiviral Aug/05/2020
Indirubin
Potential treatment - theoretical effect Experimental Antiviral Aug/05/2020
Pemirolast
Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/05/2020
Sulfanilamide
Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/05/2020
S-columbianetin
Potential treatment - theoretical effect Experimental Antiviral Aug/05/2020
N-[(3-Fluorophenyl)methyl]-1-[(1r)-1-Naphthalen-1-Ylethyl]piperidine-4-Carboxamide
Potential treatment - theoretical effect Experimental Antiviral Aug/04/2020
Pravastatin
Potential treatment - clinical evidence Used to treat other disease Other treatment Aug/04/2020
Simvastatin
Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/04/2020
Atorvastatin
Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/04/2020
Herbacetin
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020
Pectolinarin
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020
Camellia sinensis extract
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020
Terminalia chebula extract
Potential treatment - pre-clinical evidence Natural product Antiviral Aug/04/2020
Thearubigin
Potential treatment - theoretical effect Natural product Antiviral Aug/04/2020
Myricitrin
Potential treatment - theoretical effect Natural product Antiviral Aug/03/2020